{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:43:18Z","timestamp":1792093398812,"version":"4.4.0"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T00:00:00Z","timestamp":1633996800000},"content-version":"vor","delay-in-days":284,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG 08\/008"],"award-info":[{"award-number":["PG 08\/008"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016272","name":"International Atherosclerosis Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001674","name":"Fondation Leducq","doi-asserted-by":"publisher","award":["14 CVD03"],"award-info":[{"award-number":["14 CVD03"]}],"id":[{"id":"10.13039\/501100001674","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","award":["24052829"],"award-info":[{"award-number":["24052829"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jlr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/j.jlr.2021.100139","type":"journal-article","created":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T15:19:34Z","timestamp":1634570374000},"page":"100139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Genetic testing for familial hypercholesterolemia\u2014past, present, and future"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2120-2088","authenticated-orcid":false,"given":"Marta","family":"Futema","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Taylor-Beadling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maggie","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve E.","family":"Humphries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jlr.2021.100139_bib1","doi-asserted-by":"crossref","first-page":"9214","DOI":"10.1074\/jbc.M008890200","article-title":"The molecular mechanism for the genetic disorder familial defective apolipoprotein B100","volume":"276","author":"Boren","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2021.100139_bib2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ng1161","article-title":"Mutations in PCSK9 cause autosomal dominant hypercholesterolemia","volume":"34","author":"Abifadel","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jlr.2021.100139_bib3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/humu.22215","article-title":"Description of a large family with autosomal dominant hypercholesterolemia associated with the APOE p.Leu167del mutation","volume":"34","author":"Marduel","year":"2013","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.jlr.2021.100139_bib4","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/humu.23634","article-title":"ClinVar database of global familial hypercholesterolemia-associated DNA variants","volume":"39","author":"Iacocca","year":"2018","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.jlr.2021.100139_bib5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/jmedgenet-2016-104054","article-title":"The UCL low-density lipoprotein receptor gene variant database: pathogenicity update","volume":"54","author":"Leigh","year":"2017","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.jlr.2021.100139_bib6","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1161\/01.ATV.17.11.3127","article-title":"Familial hypercholesterolemia in the Finnish north Karelia. A molecular, clinical, and genealogical study","volume":"17","author":"Vuorio","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jlr.2021.100139_bib7","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1172\/JCI114258","article-title":"Two common low density lipoprotein receptor gene mutations cause familial hypercholesterolemia in Afrikaners","volume":"84","author":"Leitersdorf","year":"1989","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jlr.2021.100139_bib8","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1056\/NEJM198709173171204","article-title":"Deletion in the gene for the low-density-lipoprotein receptor in a majority of French Canadians with familial hypercholesterolemia","volume":"317","author":"Hobbs","year":"1987","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jlr.2021.100139_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016461","article-title":"Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis","volume":"7","author":"Akioyamen","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.jlr.2021.100139_bib10","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S0140-6736(85)91611-3","article-title":"A\u00a0common DNA polymorphism of the low-density lipoprotein (LDL) receptor gene and its use in diagnosis","volume":"1","author":"Humphries","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.jlr.2021.100139_bib11","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1172\/JCI114192","article-title":"Finnish type of low density lipoprotein receptor gene mutation (FH-Helsinki) deletes exons encoding the carboxy-terminal part of the receptor and creates an internalization-defective phenotype","volume":"84","author":"Aalto-Setala","year":"1989","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jlr.2021.100139_bib12","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.atherosclerosis.2006.10.003","article-title":"Genetic defects causing familial hypercholesterolaemia: identification of deletions and duplications in the LDL-receptor gene and summary of all mutations found in patients attending the Hammersmith Hospital Lipid Clinic","volume":"194","author":"Tosi","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jlr.2021.100139_bib13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1399-0004.2009.01168.x","article-title":"Multiplex ligation-dependent probe amplification analysis to screen for deletions and duplications of the LDLR gene in patients with familial hypercholesterolaemia","volume":"76","author":"Taylor","year":"2009","journal-title":"Clin. Genet."},{"key":"10.1016\/j.jlr.2021.100139_bib14","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/jmedgenet-2012-101189","article-title":"Use of targeted exome sequencing as a diagnostic tool for Familial Hypercholesterolaemia","volume":"49","author":"Futema","year":"2012","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.jlr.2021.100139_bib15","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1469-1809.2008.00436.x","article-title":"Update and analysis of the University College London low density lipoprotein receptor familial hypercholesterolemia database","volume":"72","author":"Leigh","year":"2008","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.jlr.2021.100139_bib16","first-page":"1316","article-title":"Whole-gene duplication of PCSK9 as a novel genetic mechanism for severe familial hypercholesterolemia","volume":"34","author":"Iacocca","year":"2018","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.jlr.2021.100139_bib17","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1093\/clinchem\/42.8.1140","article-title":"High sensitivity of the single-strand conformation polymorphism method for detecting sequence variations in the low-density lipoprotein receptor gene validated by DNA sequencing","volume":"42","author":"Jensen","year":"1996","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jlr.2021.100139_bib18","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1093\/clinchem\/48.11.1913","article-title":"Use of denaturing HPLC to provide efficient detection of mutations causing familial hypercholesterolemia","volume":"48","author":"Bodamer","year":"2002","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jlr.2021.100139_bib19","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1399-0004.2007.00807.x","article-title":"Multiplex ARMS analysis to detect 13 common mutations in familial hypercholesterolaemia","volume":"71","author":"Taylor","year":"2007","journal-title":"Clin. Genet."},{"key":"10.1016\/j.jlr.2021.100139_bib20","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1034\/j.1399-0004.2000.570205.x","article-title":"Molecular genetic testing for familial hypercholesterolemia: spectrum of LDL receptor gene mutations in The Netherlands","volume":"57","author":"Lombardi","year":"2000","journal-title":"Clin. Genet."},{"key":"10.1016\/j.jlr.2021.100139_bib21","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/humu.1218","article-title":"Molecular genetics of familial hypercholesterolemia in Spain: Ten novel LDLR mutations and population analysis","volume":"18","author":"Garcia-Garcia","year":"2001","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.jlr.2021.100139_bib22","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1046\/j.1365-2796.1997.78119000.x","article-title":"Molecular genetics of familial hypercholesterolaemia in Norway","volume":"241","author":"Leren","year":"1997","journal-title":"J.\u00a0Intern. Med."},{"key":"10.1016\/j.jlr.2021.100139_bib23","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/sj.ejhg.5200633","article-title":"A\u00a0molecular genetic service for diagnosing individuals with familial hypercholesterolaemia (FH) in the United Kingdom","volume":"9","author":"Heath","year":"2001","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.jlr.2021.100139_bib24","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1399-0004.2009.01356.x","article-title":"Mutation detection rate and spectrum in familial hypercholesterolaemia patients in the UK pilot cascade project","volume":"77","author":"Taylor","year":"2010","journal-title":"Clin. Genet."},{"key":"10.1016\/j.jlr.2021.100139_bib25","doi-asserted-by":"crossref","DOI":"10.1093\/database\/baaa083","article-title":"Color Data v2: a user-friendly, open-access database with hereditary cancer and hereditary cardiovascular conditions datasets","volume":"2020","author":"Berger","year":"2020","journal-title":"Database (Oxford)"},{"key":"10.1016\/j.jlr.2021.100139_bib26","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/S0002-9149(98)00215-X","article-title":"A\u00a0World Wide Web site for low-density lipoprotein receptor gene mutations in familial hypercholesterolemia: sequence-based, tabular, and direct submission data handling","volume":"81","author":"Wilson","year":"1998","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.jlr.2021.100139_bib27","doi-asserted-by":"crossref","first-page":"13282","DOI":"10.1016\/S0021-9258(18)37702-0","article-title":"Mutational analysis of the ligand binding domain of the low density lipoprotein receptor","volume":"263","author":"Esser","year":"1988","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2021.100139_bib28","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/humu.1380010602","article-title":"Molecular genetics of the LDL receptor gene in familial hypercholesterolemia","volume":"1","author":"Hobbs","year":"1992","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.jlr.2021.100139_bib29","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"10.1016\/j.jlr.2021.100139_bib30","article-title":"The Clinical Genome Resource (ClinGen) Familial Hypercholesterolemia Variant Curation Expert Panel consensus guidelines for LDLR variant classification","author":"Chora","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.jlr.2021.100139_bib31","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.atherosclerosis.2021.01.008","article-title":"Comparison of the mutation spectrum and association with pre and post treatment lipid measures of children with heterozygous familial hypercholesterolaemia (FH) from eight European countries","volume":"319","author":"Futema","year":"2021","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jlr.2021.100139_bib32","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00041433-200304000-00002","article-title":"Molecular mechanisms of autosomal recessive hypercholesterolemia","volume":"14","author":"Cohen","year":"2003","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.jlr.2021.100139_bib33","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/PAT.0000000000000026","article-title":"Diagnostic validation of a familial hypercholesterolaemia cohort provides a model for using targeted next generation DNA sequencing in the clinical setting","volume":"46","author":"Hinchcliffe","year":"2014","journal-title":"Pathology"},{"key":"10.1016\/j.jlr.2021.100139_bib34","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1016\/j.atherosclerosis.2014.08.002","article-title":"The impact of routine next generation sequencing testing for familial hypercholesterolaemia - 5 months service experience","volume":"236","author":"Yarram-Smith","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jlr.2021.100139_bib35","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1471-2350-15-70","article-title":"Targeted genetic testing for familial hypercholesterolaemia using next generation sequencing: a population-based study","volume":"15","author":"Norsworthy","year":"2014","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.jlr.2021.100139_bib36","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/joim.12263","article-title":"Genetic diagnosis of familial hypercholesterolaemia by targeted next-generation sequencing","volume":"276","author":"Maglio","year":"2014","journal-title":"J.\u00a0Intern. Med."},{"key":"10.1016\/j.jlr.2021.100139_bib37","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jacc.2018.05.044","article-title":"Convened by the familial hypercholesterolemia, F. clinical genetic testing for familial hypercholesterolemia: JACC Scientific Expert Panel","volume":"72","author":"Sturm","year":"2018","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.jlr.2021.100139_bib38","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jacl.2014.01.002","article-title":"Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation","volume":"8","author":"Watts","year":"2014","journal-title":"J.\u00a0Clin. Lipidol."},{"key":"10.1016\/j.jlr.2021.100139_bib39","series-title":"Familial hypercholesterolaemia: identification and management","year":"2019"},{"key":"10.1016\/j.jlr.2021.100139_bib40","first-page":"1553","article-title":"Canadian Cardiovascular Society position statement on familial hypercholesterolemia: Update 2018","volume":"34","author":"Brunham","year":"2018","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.jlr.2021.100139_bib41","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.atherosclerosis.2019.08.014","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk","volume":"290","author":"Mach","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jlr.2021.100139_bib42","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1093\/eurheartj\/ehx111","article-title":"Cost effectiveness of cascade testing for familial hypercholesterolaemia, based on data from familial hypercholesterolaemia services in the UK","volume":"38","author":"Kerr","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jlr.2021.100139_bib43","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jacl.2017.01.002","article-title":"Cost-effectiveness of a cascade screening program for the early detection of familial hypercholesterolemia","volume":"11","author":"Lazaro","year":"2017","journal-title":"J.\u00a0Clin. Lipidol."},{"key":"10.1016\/j.jlr.2021.100139_bib44","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.atherosclerosissup.2017.05.019","article-title":"Cascade screening for familial hypercholesterolemia: Practical consequences","volume":"30","author":"Louter","year":"2017","journal-title":"Atheroscler. Suppl."},{"key":"10.1016\/j.jlr.2021.100139_bib45","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1093\/eurheartj\/ehs038","article-title":"Cardiovascular risk in relation to functionality of sequence variants in the gene coding for the low-density lipoprotein receptor: a study among 29,365 individuals tested for 64 specific low-density lipoprotein-receptor sequence variants","volume":"33","author":"Huijgen","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jlr.2021.100139_bib46","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1136\/jmg.2006.038356","article-title":"Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk","volume":"43","author":"Humphries","year":"2006","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.jlr.2021.100139_bib47","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1093\/eurheartj\/ehw028","article-title":"Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217","volume":"37","author":"Benn","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jlr.2021.100139_bib48","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.atherosclerosis.2014.11.015","article-title":"Prevalence and clinical correlates of familial hypercholesterolemia founder mutations in the general population","volume":"238","author":"Lahtinen","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jlr.2021.100139_bib49","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.atherosclerosissup.2018.07.028","article-title":"Familial hypercholesterolaemia (fh) genetic testing in the UK","volume":"34","author":"Haralambos","year":"2018","journal-title":"Atheroscler. Suppl."},{"key":"10.1016\/j.jlr.2021.100139_bib50","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/ejhg.2014.199","article-title":"Functional analysis of four LDLR 5'UTR and promoter variants in patients with familial hypercholesterolaemia","volume":"23","author":"Khamis","year":"2015","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.jlr.2021.100139_bib51","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/hmg\/5.9.1325","article-title":"Genetic variation at a splicing branch point in intron 9 of the low density lipoprotein (LDL)-receptor gene: a rare mutation that disrupts mRNA splicing in a patient with familial hypercholesterolaemia and a common polymorphism","volume":"5","author":"Webb","year":"1996","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jlr.2021.100139_bib52","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3389\/fgene.2020.00691","article-title":"Low density lipoprotein receptor variants in the beta-propeller subdomain and their functional impact","volume":"11","author":"Duskova","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.jlr.2021.100139_bib53","doi-asserted-by":"crossref","first-page":"E76","DOI":"10.1161\/01.ATV.20.10.e76","article-title":"R3531C mutation in the apolipoprotein B gene is not sufficient to cause hypercholesterolemia","volume":"20","author":"Rabes","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jlr.2021.100139_bib54","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1161\/01.ATV.15.8.1025","article-title":"Independent mutations at codon 3500 of the apolipoprotein B gene are associated with hyperlipidemia","volume":"15","author":"Gaffney","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jlr.2021.100139_bib55","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/mgg3.17","article-title":"Identification and biochemical analysis of a novel APOB mutation that causes autosomal dominant hypercholesterolemia","volume":"1","author":"Thomas","year":"2013","journal-title":"Mol. Genet. Genomic Med."},{"key":"10.1016\/j.jlr.2021.100139_bib56","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1093\/hmg\/ddt573","article-title":"Novel functional APOB mutations outside LDL-binding region causing familial hypercholesterolaemia","volume":"23","author":"Alves","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jlr.2021.100139_bib57","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.atherosclerosis.2018.06.819","article-title":"Further evidence of novel APOB mutations as a cause of familial hypercholesterolaemia","volume":"277","author":"Alves","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jlr.2021.100139_bib58","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.atherosclerosis.2013.04.011","article-title":"Analysis of the frequency and spectrum of mutations recognised to cause familial hypercholesterolaemia in routine clinical practice in a UK specialist hospital lipid clinic","volume":"229","author":"Futema","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jlr.2021.100139_bib59","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.atherosclerosis.2005.02.016","article-title":"Genetic screening protocol for familial hypercholesterolemia which includes splicing defects gives an improved mutation detection rate","volume":"182","author":"Graham","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jlr.2021.100139_bib60","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.atherosclerosis.2015.03.003","article-title":"Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales","volume":"240","author":"Haralambos","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jlr.2021.100139_bib61","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(12)62127-8","article-title":"Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study","volume":"381","author":"Talmud","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jlr.2021.100139_bib62","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1373\/clinchem.2014.231365","article-title":"Refinement of variant selection for the LDL cholesterol genetic risk score in the diagnosis of the polygenic form of clinical familial hypercholesterolemia and replication in samples from 6 countries","volume":"61","author":"Futema","year":"2015","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jlr.2021.100139_bib63","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK Biobank resource with deep phenotyping and genomic data","volume":"562","author":"Bycroft","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jlr.2021.100139_bib64","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.atherosclerosis.2017.05.015","article-title":"Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemia","volume":"263","author":"Sharifi","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jlr.2021.100139_bib65","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/j.jacc.2016.03.520","article-title":"Diagnostic yield of sequencing familial hypercholesterolemia genes in patients with severe hypercholesterolemia","volume":"67","author":"Khera","year":"2016","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.jlr.2021.100139_bib66","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jacc.2019.05.043","article-title":"Risk of premature atherosclerotic disease in patients with monogenic versus polygenic familial hypercholesterolemia","volume":"74","author":"Trinder","year":"2019","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.jlr.2021.100139_bib67","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1161\/CIRCULATIONAHA.115.020109","article-title":"Incorporating a genetic risk score into coronary heart disease risk estimates: Effect on low-density lipoprotein cholesterol levels (the MI-GENES Clinical Trial)","volume":"133","author":"Kullo","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jlr.2021.100139_bib68","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1161\/CIRCGEN.120.002919","article-title":"Polygenic contribution to low-density lipoprotein cholesterol levels and cardiovascular risk in monogenic familial hypercholesterolemia","volume":"13","author":"Trinder","year":"2020","journal-title":"Circ. Genom. Precis Med."},{"key":"10.1016\/j.jlr.2021.100139_bib69","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jacl.2020.02.001","article-title":"Patient acceptance of genetic testing for familial hypercholesterolemia in the CASCADE FH Registry","volume":"14","author":"Gidding","year":"2020","journal-title":"J.\u00a0Clin. Lipidol."},{"key":"10.1016\/j.jlr.2021.100139_bib70","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/j.jacc.2018.07.079","article-title":"Genomic risk prediction of coronary artery disease in 480,000 adults: Implications for primary prevention","volume":"72","author":"Inouye","year":"2018","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.jlr.2021.100139_bib71","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jacl.2019.01.010","article-title":"LDL-cholesterol goal achievement, cardiovascular disease, and attributed risk of Lp(a) in a large cohort of predominantly genetically verified familial hypercholesterolemia","volume":"13","author":"Bogsrud","year":"2019","journal-title":"J.\u00a0Clin. Lipidol."},{"key":"10.1016\/j.jlr.2021.100139_bib72","first-page":"1","article-title":"Clinical utility of lipoprotein(a) and LPA genetic risk score in risk prediction of incident atherosclerotic cardiovascular disease","volume":"6","author":"Trinder","year":"2020","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.jlr.2021.100139_bib73","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1056\/NEJMoa1602777","article-title":"Child-parent familial hypercholesterolemia screening in primary care","volume":"375","author":"Wald","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jlr.2021.100139_bib74","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.atherosclerosis.2017.03.007","article-title":"Screening for familial hypercholesterolaemia in childhood: Avon Longitudinal Study of Parents and Children (ALSPAC)","volume":"260","author":"Futema","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jlr.2021.100139_bib75","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.atherosclerosis.2019.11.028","article-title":"Reaching detection targets in familial hypercholesterolaemia: Comparison of identification strategies","volume":"293","author":"Wald","year":"2020","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jlr.2021.100139_bib76","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.atherosclerosis.2018.05.047","article-title":"Universal screening at age 1-2 years as an adjunct to cascade testing for familial hypercholesterolaemia in the UK: A cost-utility analysis","volume":"275","author":"McKay","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jlr.2021.100139_bib77","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.atherosclerosis.2018.06.858","article-title":"Universal screening for familial hypercholesterolemia in children: The Slovenian model and literature review","volume":"277","author":"Groselj","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jlr.2021.100139_bib78","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/gim.2013.73","article-title":"ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing","volume":"15","author":"Green","year":"2013","journal-title":"Genet. Med."},{"key":"10.1016\/j.jlr.2021.100139_bib79","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/jmedgenet-2014-102405","article-title":"Whole exome sequencing of familial hypercholesterolaemia patients negative for LDLR\/APOB\/PCSK9 mutations","volume":"51","author":"Futema","year":"2014","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.jlr.2021.100139_bib80","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/CIRCRESAHA.115.304660","article-title":"Mutations in STAP1 are associated with autosomal dominant hypercholesterolemia","volume":"115","author":"Fouchier","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.jlr.2021.100139_bib81","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1161\/ATVBAHA.119.313470","article-title":"Taking\u00a0one step back in familial hypercholesterolemia: stap1 does not alter plasma ldl (low-density lipoprotein) cholesterol in mice and humans","volume":"40","author":"Loaiza","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jlr.2021.100139_bib82","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.atherosclerosis.2019.11.025","article-title":"Predicted pathogenic mutations in STAP1 are not associated with clinically defined familial hypercholesterolemia","volume":"292","author":"Lamiquiz-Moneo","year":"2020","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jlr.2021.100139_bib83","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/jhg.2010.87","article-title":"Analysis of LDLR mRNA in patients with familial hypercholesterolemia revealed a novel mutation in intron 14, which activates a cryptic splice site","volume":"55","author":"Kulseth","year":"2010","journal-title":"J.\u00a0Hum. Genet."},{"key":"10.1016\/j.jlr.2021.100139_bib84","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jlr.2021.100139_bib85","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.atherosclerosis.2018.08.051","article-title":"Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)","volume":"277","author":"Vallejo-Vaz","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jlr.2021.100139_bib86","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/jamacardio.2019.5173","article-title":"Reducing the clinical and public health burden of familial hypercholesterolemia: A global call to action","volume":"5","author":"Wilemon","year":"2020","journal-title":"JAMA Cardiol."}],"updated-by":[{"DOI":"10.1016\/j.jlr.2021.100146","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000}}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227521001218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227521001218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T06:52:30Z","timestamp":1777445550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227521001218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":86,"alternative-id":["S0022227521001218"],"URL":"https:\/\/doi.org\/10.1016\/j.jlr.2021.100139","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic testing for familial hypercholesterolemia\u2014past, present, and future","name":"articletitle","label":"Article Title"},{"value":"Journal of Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jlr.2021.100139","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"100139"}}